Earlier this month, the World Steel Association released its “Short Range Outlook” for apparent steel use (ASU) for 2014 and 2015. In 2013, ASU reached 1,481 megatons, an increase of 3.6%. ASU is forecast to grow 3.1% in 2014 and 3.3% in 2015. In 2013, developing economies’ ASU was almost triple that of developed economies, […]
Spokane, WA 4/30/14—The Spokesman-Review has reported that PerkinElmer will close its Signature Genomics business later this year. Signature provides microarray-based prenatal and other genetics testing services. PerkinElmer told the Spokesman-Review, “Changing market conditions, including a highly unfavorable reimbursement environment, combined with a significant decline in demand for invasive procedures due to the uptake of non-invasive […]
Loveland, CO 4/2/14—Hach, a Danaher company and provider of analytical instruments and reagents for water quality analysis, has acquired BioTector Analytical Systems for an undisclosed amount. Based in Ireland, BioTector designs and manufactures online liquid analyzers, including systems for online TOC analysis. BioTector has more than 1,500 installations. Hach has distributed BioTector products since 2010.
Beijing, China 4/29/14—Global alternative-asset manager the Carlyle Group has agreed to acquire a 30% stake in Haier Bio-Medical and Laboratory (HBML) for CNY 405 million ($65 million = CNY 6.23 = $1) through its Carlyle Beijing Partners Fund. A subsidiary of Haier, HBML develops and manufactures biomedical and lab equipment for the Chinese and global […]
The US equity markets wavered in April as a result of mixed earnings and economic data. While manufacturing reports and consumer sentiment improved, the housing markets and GDP growth concerned investors. First quarter US GDP grew at a lackluster 0.1%, which was below analysts’ expectations of 1.1% and significantly lower than the 2.6% growth in […]
Company Announcements Roche’s 2013 sales of nucleic acid purification/real-time PCR reagents and systems in the life sciences market grew 6%. QIAGEN adjusted fourth quarter 2013 sales grew 4.6%, 2% organically, to $362.6 million (see IBO 1/31/14). All figures below are on a currency-neutral basis. Consumables and related sales expanded 7%, 3% excluding acquisitions, to make […]
Fourth quarter 2013 IBO Lab Equipment/Consumables Sales Index revenues grew 3.7%, 4.9% excluding currency, to $4,474 million. Adjusted operating profit rose 10.0% to $809 million. Operating margin gained 90 basis points to 16.4% of sales. Full-year 2013 Index sales grew 1.7%, 2.8% excluding currency, to $16,759 million. Adjusted operating profit rose 2.3% to $2,956 million. […]
Paris, France 4/1/14; Paris, France 4/7/14—Molecular diagnostics firm Genomic Vision has completed its IPO, listing its shares on the Euronext Paris stock exchange (see IBO 3/31/14). The company’s shares began trading on April 7 at a price of €15.00 ($20.55 = €0.73= $1) per share, the middle of the expected pricing range. The offering raised […]
Notwithstanding currency, there were only subtle changes in the 2013 calendar-year rankings on IBO’s list of the top 30 analytical and life science instrument and aftermarket companies as a result of modest growth and fewer acquisitions. However, Illumina was the highlight, rising one spot to the number nine position, with more than 20% sales growth […]
Washington, DC 3/18/14—Bio-Rad Laboratories reported in its annual 10K SEC filing for 2013 that it has identified a material weakness in its internal control over financial reporting. This follows the company’s identification of other material weaknesses in internal controls in 2011 and 2012 (see IBO 4/30/13). In its latest 10K filing, the company stated, “we […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
